Nature Reviews Drug Discovery

The Biomarkers Consortium: 20 years of advancing precision medicine

A Amanda Klein J Jeffrey Siegel S Steve Hoffmann J Jennifer D. Hamilton H Hearn Jay Cho D Douglas R. Lowy J John A. Wagner
Download PDF View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 25, Issue 3
Published March 01, 2026
Pages 155-156
ISSN 1474-1776
Publisher Springer Science and Business Media LLC

Journal Info

Nature Reviews Drug Discovery

Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine

Authors (7)

A

Amanda Klein

J

Jeffrey Siegel

S

Steve Hoffmann

J

Jennifer D. Hamilton

H

Hearn Jay Cho

D

Douglas R. Lowy

J

John A. Wagner

Related Articles from this Journal

Can multispecific biologics break the efficacy ceiling?

Asher Mullard Jul 2026 10.1038/d41573-026-00106-5

Novel drug targets in 2025

Sorin Avram, Liliana Halip et al. Jul 2026 10.1038/d41573-026-00102-9

The unglamourous AI wins that are quietly transforming drug discovery and development

Asher Mullard Jul 2026 10.1038/d41573-026-00099-1

Upcoming FDA approval decisions in Q3 2026

Swetha Kota Jul 2026 10.1038/d41573-026-00103-8

Antiviral peptide nabs FDA approval for hepatitis delta virus infection

Asher Mullard Jul 2026 10.1038/d41573-026-00101-w